CureDM Announces Acquisition by Boston Therapeutics
February 13, 2018
Download
CureDM Receives High Marks for Participation in BiotoChina Investor Conference
October 26, 2017
Download
CureDM Files Annual Report with the US FDA
October 12, 2017
Download
CureDM Participates in the 14th Redefining Early Stage Investments Conference
September 20, 2017
Download
CureDM Participates in 2017 BIT's 5th Annual World Congress of Diabetes
July 11, 2017
Download
CureDM Participates in 2017 RESI San Francisco
January 9, 2017
Download
CureDM Announces New Board Members,
Kevin Kaster, JD and John Amatruda, MD
September 27, 2016
Download CureDM Announces New CEO, Loraine V. Upham
September 7, 2016
Download
CureDM Announces Results of Phase 1b Study
in Type 2 Diabetes Patients
March 20, 2016
Download ADA 2016 Poster
Download CureDM Collaborates with University of New Mexico
in Pancreatic Progenitor Cell Study
February 7, 2014
Download
PAS 2014 Poster
Download
CureDM Initiates Phase 1b Safety Study in type 2 Diabetes Patients
September 10, 2013
Download
CureDM Completes Phase 1a Clinical Safety Study
December 20, 2012
Download
CureDM Receives IND Approval for Phase 1a Clinical Safety Study
July 24, 2012
Download
CureDM Partners Novel Diabetes Treatment
with Sanofi-Aventis
April 8, 2010
Download
New Diabetes Patent Allowance for CureDM, Inc.
December 14, 2009
Download
Claresa Levetan MD, Co-Founder, CureDM, Inc.,
Selected for the Class of 2009 Women of Distinction
by Philadelphia Business Journal
November 30, 2009
Download
CureDM featured in Diabetes Health article
entitled "Promising Pancreate Creates New Islets"
September 28, 2009
Link to Article
CureDM Awarded 2009 Diabetes Product
Innovation of the Year by Frost and Sullivan
September 8, 2009
Download
Award
Photo
Novel Diabetes Drug Discovery Has
Potential to Reverse Diabetes
January 27, 2009
Download
CureDM's Diabetes Therapy Achieves
Major Development
April 30, 2008
Download
CureDM Founder Claresa S. Levetan, MD
receives Clinical Endocrinology Award
March 27, 2007
Download
Photo
Lankenau Hospital physicians research a
new treatment for diabetes
March 20, 2007
Download
Photo
CureDM, Inc. Achieves Two Drug Discovery
Milestones
February 22, 2007
Download
Calvert Research Institute Newsletter
March / April 2007
Download
CureDM, Inc. Story Published in the December 2006/January 2007
Edition of the New Jersey TechNews
January 2007
Download
CureDM, Inc. Announces the Closing of a
Series B Stock Placement
November 30, 2006
Download
Calvert Holdings, Inc. Announces Investment in
CureDM, Inc.
November 2, 2006
Download
CureDM, Inc. Announces the Appointment of
John H. Dillon, II to the Board of Directors
October 26, 2006
Download
CureDM, Inc. Announces Diabetes Research Collaboration with the
Lankenau Institute for Medical Research
September 8, 2006
Download
CureDM, Inc. Announces the Appointment of
Stephen M. McLean to the Board of Directors
April 25, 2006
Download
PDF Documents require the Adobe Acrobat Reader |